Ready to play
Ready to play
The Democratic Republic of the Congo received 16,000 doses of the "Ervebo" Ebola vaccine amid the most severe and deadly outbreak of the virus in the country's history, with over 5,290 cases and 2,516 deaths recorded so far. This follows the World Health Organization's announcement of providing 70,000 doses of the vaccine, produced in Germany, to assist in combating the epidemic—with a primary focus on using 20,000 doses in clinical trials and 50,000 for healthcare teams. Although the vaccine has proven effective against the Zaire strain, its efficacy against the Bondo Bago strain remains uncertain, though preliminary data suggest it may offer some protection. This collaboration comes as efforts to contain the rapidly spreading virus intensify, especially in areas with weak healthcare infrastructure and active armed groups. Meanwhile, scientists continue to develop additional vaccines to address the new strain.
Notice: This Is an AI-Generated Summary
Comments (0)